ArticleResearch square2026

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

Eric J Malmberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.